Fairscale Capital, LLC Ark Genomic Revolution ETF (De Transaction History
Fairscale Capital, LLC
- $116 Billion
- Q4 2024
A detailed history of Fairscale Capital, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Fairscale Capital, LLC holds 642 shares of ARKG stock, worth $13,270. This represents 0.01% of its overall portfolio holdings.
Number of Shares
642
Previous 642
-0.0%
Holding current value
$13,270
Previous $16.4 Million
8.03%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
282Shares Held
23.3MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$75 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$72 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$57.7 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$57.5 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$34.2 Million0.02% of portfolio